
View/ Open
jameson_et_al_2022.pdf (157.7Kb)
Download
Publication date
10/08/2022Author
Jameson, A.Fylan, Beth

Bristow, Greg C.
Cardno, A.
Dalton, C.
Sagoo, G.
Sohal, J.
McLean, Samantha

Rights
(c) 2022 The Pharmaceutical Journal. Full-text reproduced in accordance with the publisher's self-archiving policy.Peer-Reviewed
YesOpen Access status
openAccessAccepted for publication
13/07/2023
Metadata
Show full item recordAbstract
Patients' pharmacogenetic data could be used to improve adherence to antipsychotic medication by increasing the likelihood of therapeutic response and reducing the prevalence of adverse drug reactions.Version
Accepted manuscriptCitation
Jameson A, Fylan B, Bristow GC et al (2022) Pharmacogenomics is the future of prescribing in psychiatry. Pharmaceutical Journal. 209: 7964.Link to Version of Record
https://doi.org/10.1211/PJ.2022.1.152215Type
Articleae974a485f413a2113503eed53cd6c53
https://doi.org/10.1211/PJ.2022.1.152215